Has Geoffrey van Thiel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $351,260 in general payments to Geoffrey van Thiel, MD across 356 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Geoffrey van Thiel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Geoffrey van Thiel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Geoffrey van Thiel, MD

Orthopaedic Surgery · Rockford, ILNPI 1316103971

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $228,614 of the $351,260 with a category attached, or 65.1%. 11 manufacturers reported payments, led by Smith+Nephew at 58.7% of the total. Reporting peaked in 2019 at $103,277 and has fallen 69.7% since, to $31,285 in 2025. Among orthopaedic surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$351,260in general payments, 2019–2025

Across 356 payments — averaging $986.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$206K
Vericel Corporation$114K
Bioventus LLC$13K
Anika Therapeutics, Inc.$12K
Graymont Professional Products IP, LLC$6K
Stryker$298
plus $446 from 5 others

$157,583in research payments, 2019–2025

Across 81 payments — averaging $1945.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Smith+Nephew$102K
Vericel Corporation$23K
Anika Therapeutics, Inc.$18K
Zimmer Biomet$15K

What the payments were for

Royalty or licence$5,0001%
Consulting fees$74,98421%
Speaking & faculty fees$228,61465%
Travel & lodging$32,0809%
Food & beverage$10,5813%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	190	$206,083
Vericel Corporation	116	$113,987
Bioventus LLC	20	$12,800
Anika Therapeutics, Inc.	14	$11,521
Graymont Professional Products IP, LLC	2	$6,125
Stryker	5	$298
DJO, LLC	4	$164
Globus Medical	1	$143
Pacira Pharmaceuticals Incorporated	2	$50
Si-bone, Inc.	1	$48
Lima USA, Inc.	1	$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MACI$108,720
SPATIAL FRAME$35,112
Q-FIX$34,408
Firstpass$32,821
Fast-Fix 360$30,659
MICRORAPTOR$28,033
BIOSURE REGENESORB$25,871
Healicoil$22,749
Accu-pass$20,790
Bone Anchors with Arthroscopic Delivery System$19,681
CAP-FIX$15,874
Coblation Wands$14,840
Acufex$13,603
Dyonics Powermini/Powermax$11,360
HYALOFAST$10,743
Bioinductive Implant with Arthroscopic Delivery System - Medium$10,625
FIRSTPASS MINI$10,566
Acufex Director$9,149
FAST-FIX$8,782
ACCUPASS DIRECT Crescent XL$8,763

How this compares

$351,260 in reported general payments places this provider in the 95th percentile of 844 orthopaedic surgery providers in Illinois.

See all orthopaedic surgery providers in Illinois →

Medicare billing

Part B allowed, 2024

$108,613

Medicare patients

292

Services billed

2,530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Methylprednisolone	131	$560
Meloxicam	75	$157
Cyclobenzaprine Hcl	16	$140
Celecoxib	14	$128
Naproxen	15	$38

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Rockford

Scott TrenhaileRockford$1.7M
Brian BearRockford$168K
Peter BonuttiEffingham$24.3M
Steven HaddadGlenview$12.6M
Aaron RosenbergChicago$12.4M
Treg BrownHerrin$6.6M
Wayne GoldsteinMorton Grove$4.9M
Steven ChudikWestmont$4.1M
Matthew SquireAurora$2.9M
David ManningBurr Ridge$2.3M

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →